Table 4. Adverse events in all patients graded based on CTCAE 4.0 (N=30).

Adverse event	n (%)
	Grade 1	Grade 2	Grade 3	Total
CTCAE, Common Terminology Criteria for Adverse Events.
Hypertension	5 (16.7)	8 (26.6)	2 (6.7)	15 (50.0)
Proteinuria	3 (10.0)	1 (3.3)	6 (20.0)	10 (33.3)
Nausea	1 (3.3)	3 (10.0)	0 (0)	4 (13.3)
Vomiting	1 (3.3)	1 (3.3)	0 (0)	2 (6.7)
Fatigue	2 (6.7)	1 (3.3)	1 (3.3)	4 (13.3)
Infection	0 (0)	1 (3.3)	0 (0)	1 (3.3)
Bleeding	0 (0)	1 (3.3)	0 (0)	1 (3.3)
Decreased appetite	1 (3.3)	1 (3.3)	0 (0)	2 (6.7)
Headache	0 (0)	1 (3.3)	0 (0)	1 (3.3)
Bilirubin increased	1 (3.3)	0 (0)	2 (6.7)	3 (10.0)
Transaminase increased	0 (0)	0 (0)	1 (3.3)	1 (3.3)
Leukopenia	1 (3.3)	0 (0)	0 (0)	1 (3.3)
Hypokalemia	0 (0)	1 (3.3)	0 (0)	1 (3.3)
Oral ulcer	0 (0)	1 (3.3)	0 (0)	1 (3.3)
Total	15 (50.0)	20 (66.6)	12 (40.0)	−